Bedaquiline Catalog No.:M8161-2 also known as Donaxine

also known as Donaxine

550(7677):534-538

Binding studies indicate that it has no effect on monoamine uptake and no affinity for α

dark and at 0-4oC for short term (days to weeks) or -20oC for long term (months to years)

Smiles: CC1N=C(SC=1S(N)(=O)=O)N(C)C(=O)CC1=CC=C(C=C1)C1=CC=CC=N1

Bedaquiline Catalog No.:M8161-2 also known as DonaxineBedaquiline, also known as TMC207 and R207910, is a diarylquinoline anti tuberculosis drug, which was discovered by a team led by Koen Andries at Janssen Pharmaceutica. Bedaquiline blocks the proton pump for ATP synthase of mycobacteria. ATP production is required for cellular energy production and its loss leads to cell death, even in dormant or nonreplicating mycobacteria. It is the first member of a new class of drugs called the diarylquinolines.